The phrase "application patent" is correct and usable in written English.
It is typically used in the context of intellectual property to refer to a patent that is filed for a specific application or invention.
Example: "The inventor submitted an application patent to protect their innovative design for a new type of solar panel."
Alternatives: "patent application" or "filed patent".
We added another column, grouping country codes into one of the following groups: International patent application – according to Patent Cooperation Treaty (PCT) European patent application Patent application in Germany Patent application in other countries We added a column "weighting".
The office announced this month that it would now accept credit card payments for the basic filing fee for a patent application, patent maintenance fees, and fees for trademark applications for registration or renewal.
If they fail to respond to a request from a patent office for more information within a set time limit, fail to pay related fees or write in to cancel their application, patent office officials can judge it to be abandoned.
The VU University Medical Center has filed a patent application (patent file number P086657EP00, 'Predicting clinical response to treatment with a soluble TNF-antagonist or TNF, or a TNF receptor agonist').
Some information in this publication is related to a patent application (patent number WO 2012/143407 (26.10.12), Culture medium suitable for the culture of undifferentiated cells) by The Friedrich Miescher Institute for Biomedical Research.
Correspondence respecting patent applications, patent reexamination proceedings, and other proceedings.
37 CFR § 1.33 - Correspondence respecting patent applications, patent reexamination proceedings, and other proceedings.
§ 1.33 Correspondence respecting patent applications, patent reexamination proceedings, and other proceedings.
If an FDA approved drug is found to be effective against the pathogen of interest, a 'change-of-application' patent could be sought.
These drugs can then be rapidly moved into Phase IV clinical studies under 'change-of-application' patents.
§ 3863.1-1 Application for patent.
